$0.50
1.83% yesterday
Nasdaq, Aug 12, 09:07 pm CET
ISIN
US09074H1041
Symbol
BTCY

Biotricity Inc Stock price

$0.50
+0.09 22.07% 1M
+0.13 36.95% 6M
+0.21 72.47% YTD
+0.07 16.28% 1Y
-3.08 86.03% 3Y
-0.76 60.32% 5Y
-2.15 81.13% 10Y
-2.15 81.13% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.01 1.83%
ISIN
US09074H1041
Symbol
BTCY

Key metrics

Basic
Market capitalization
$13.1m
Enterprise Value
$37.0m
Net debt
$23.9m
Cash
$510.0k
Shares outstanding
24.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.0 | 0.9
EV/Sales
2.8 | 2.6
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-504.4%
Return on Equity
49.8%
ROCE
30.6%
ROIC
-1,131.2%
Debt/Equity
-0.8
Financials (TTM | estimate)
Revenue
$13.3m | $14.0m
EBITDA
$-4.6m | -
EBIT
$-4.6m | $-2.3m
Net Income
$-14.3m | $-14.5m
Free Cash Flow
$-3.2m
Growth (TTM | estimate)
Revenue
14.2% | 15.9%
EBITDA
11.6% | -
EBIT
11.7% | 59.6%
Net Income
7.0% | 2.7%
Free Cash Flow
57.5%
Margin (TTM | estimate)
Gross
74.3%
EBITDA
-34.9% | -
EBIT
-35.0%
Net
-108.0% | -104.0%
Free Cash Flow
-23.7%
More
EPS
$-0.6
FCF per Share
$-0.1
Short interest
2.3%
Employees
55
Rev per Employee
$220.0k
Show more

Is Biotricity Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Biotricity Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Biotricity Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Biotricity Inc forecast:

Hold
50%
Sell
50%

Financial data from Biotricity Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
13 13
14% 14%
100%
- Direct Costs 3.41 3.41
15% 15%
26%
9.86 9.86
29% 29%
74%
- Selling and Administrative Expenses 11 11
10% 10%
86%
- Research and Development Expense 2.29 2.29
11% 11%
17%
-4.63 -4.63
12% 12%
-35%
- Depreciation and Amortization 0.01 0.01
0% 0%
0%
EBIT (Operating Income) EBIT -4.64 -4.64
12% 12%
-35%
Net Profit -14 -14
7% 7%
-108%

In millions USD.

Don't miss a Thing! We will send you all news about Biotricity Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biotricity Inc Stock News

Neutral
GlobeNewsWire
about 10 hours ago
Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA
Neutral
Seeking Alpha
7 days ago
The Purpose Bitcoin Yield ETF (BTCY:CA) generates income by writing call options on Bitcoin, sacrificing some upside for current yield. This strategy suits investors seeking income from Bitcoin, but not those focused on maximizing capital appreciation from BTC's price growth. BTCY:CA offers a high distribution yield (around 17.7%), but comes with significant volatility and liquidity concerns, i...
Neutral
Seeking Alpha
25 days ago
Biotricity, Inc. (OTC:BTCY) Q4 2025 Earnings Call July 18, 2025 4:45 PM ET Company Participants S. John Ayanoglou - Chief Financial Officer Waqaas Al-Siddiq - Founder, President, CEO & Chairman Conference Call Participants Michael John Donovan - H.C.
More Biotricity Inc News

Company Profile

Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Waqaas Al-Siddiq
Employees 55
Founded 2012
Website www.biotricity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today